WOBURN, Mass.--(BUSINESS WIRE)--March 8, 2006--BioTrove, Inc. announced today that the company has successfully completed its latest fundraising by closing an additional $7 million in an oversubscribed round of venture capital funding. This brings the total amount raised since July 2005 to $15 million. Participating investors include Catalyst Health and Technology Partners, Echelon Ventures, Fletcher Spaght, and CB Health Ventures. The proceeds of this round will accelerate the commercialization of BioTrove's OpenArray(TM) genomics and RapidFire(TM) pharmaceutical screening products.